Ensayos clínicos A continuación, se enumeran los ensayos clínicos actuales.98 estudios en Gastroenterología y Hepatología (solo estudios abiertos). Filtra esta lista de estudios por sede, estatus, etc. Obesity Treatment Outcomes in Liver Transplant Recipients Scottsdale/Phoenix, Ariz. The purpose of this study is to prospectively evaluate the safety and effectiveness of standard of care, individualized, comprehensive weight loss interventions in carefully selected patients with obesity undergoing liver transplant evaluation, including utilization of best lifestyle modifications and guidance to promote a healthy weight, possible medical therapy using FDA-approved weight loss medications and EBMTs with or without concomitant medical therapy. A Study to Evaluate the Safety, Tolerability, and Determine the Optimal Dose for the Expansion Cohorts of VSV-IFNβ-NIS in Combination with Pembrolizumab in Patients with Refractory Solid Tumors Rochester, Minn. The purpose of this study is to determine the safety of VSV-IFNβ-NIS in combination with pembrolizumab, followed by expansion to examine effectiveness of combination therapy in patients with refractory Non-Small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC). A Study to Evaluate Evacuation Mechanisms Using Advanced Brain Imaging Rochester, Minn. The objective of this study is to compare the central neural circuitry with fMRI (7T) in 30 asymptomatic healthy controls, 30 constipated patients without DD, and 30 constipated patients with DD at rest (functional connectivity analysis), during rectal distention to desire to defecate and urgency, and during evacuation. A Safety to Evaluate the Safety and Effectiveness of Pressurized Intraperitoneal Aerosolized Chemotherapy in Ovarian, Uterine, Colorectal, and Gastric Cancer Patients Jacksonville, Fla. The purpose of this study is to evaluate the safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in 2 groups of patients with peritoneal carcinomatosis (PC), either due to primary ovarian, uterine, or gastric carcinoma (Arm 1) or to primary colorectal carcinoma (Arm 2), based on treatment-related adverse events reported by National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. A Study to Evaluate the Effects of Tradipitant on Satiation, Gastric Volume, Gastric Accommodation, and Gastric Emptying in Healthy Volunteers Rochester, Minn. The purpose of this study is to evaluate the effects of tradipitant relative to placebo in healthy volunteers: Difference in fasting GV; Difference in postprandial GV and in accommodation volume (that is, postprandial minus fasting gastric volumes); Difference in gastric emptying (T1/2, emptying at 2h and emptying at 4h); Volume to fullness (sensation of usual postprandial fullness) and maximum feeling of fullness (MTV). A Study to Assess Intestinal Barrier Function and Permeability in Patients with Functional Dyspepsia Jacksonville, Fla. The purpose of this study is to investigate, using several novel techniques, potential pathophysiologic abnormalities that could lead to the development of symptoms of functional dyspepsia. A Study to Evaluate the Effectiveness of Diaphragmatic Breathing on Reflux Symptoms in Outpatients Jacksonville, Fla. The purpose of this study is to establish if abdominal breathing exercises can reduce symptoms associated with reflux. Effect of Cholecystokinin (CCK) on Gastroduodenal Activity in Humans Rochester, Minn. The purpose of this research study to compare the effects a hormone cholecystokinin (CCK) in the bloodstream in healthy people and in patients with rapid gastric emptying. CCK regulates (controls) the rate at which food empties from the stomach into the small intestine. We want to learn how CCK affects the activity of the stomach and small intestines in patients with rapid gastric emptying. We are also trying to learn if genes regulate the effects of CCK. A Study of Intratumoral Injection of Dendritic Cells after High-Dose Conformal External Beam Radiotherapy in Patients with Unresectable Liver Cancer Rochester, Minn. Group 1: The primary purpose of this study is to evaluate the safety and tolerability of an autologous dendritic cells (DC) vaccine delivered by intra-tumoral injection in patients with primary liver cancer treated with high-dose conformal external beam radiotherapy (EBRT). Group 2: The primary purpose of this study is to estimate the progression-free survival rate at 2 years post-registration to see if treatment is efficacious compared to historical data Mayo Clinic Inflammatory Bowel Disease Repository Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this research study is to collect clinical information and human samples from patients with IBD. The data collected will be used to create an organized, accessible resource of human samples for biological research in IBD. Numeración de páginas Estudios clínicos AnteriorPágina anterior Ir a página 55 Ir a página 66 Ir a página 77 Ir a página 88 Ir a página 99 SiguientePróxima página Solicite una consulta Conocimientos y categoríasInvestigación May 30, 2024 Comparte en: FacebookTwitter U.S. News & World Report reconoce a Mayo Clinic de Rochester, Minnesota, como el mejor hospital del país para gastroenterología y cirugía gastrointestinal en el período 2024-2025. Obtén más información sobre este gran honor Gastroenterología y HepatologíaPágina inicialdel departamentoSeccionesPanorama generalAnálisis y procedimientosEnfermedades tratadasMédicosMédicos por sede y especialidadGrupos por especialidadConocimientos y categoríasEnsayos clínicosInvestigaciónHistorias de pacientesCostos y seguroNoticias de Mayo ClinicRemisiones Investigación: los pacientes son la prioridad Mostrar la transcripción Para video Investigación: los pacientes son la prioridad [SUENA MÚSICA] Dr. Joseph Sirven, profesor de Neurología, Mayo Clinic: La misión de Mayo se centra en el paciente. La prioridad es el paciente. Aquí, la misión y la investigación se hacen para progresar en la forma de ayudar mejor al paciente y para asegurarnos de que el paciente sea la prioridad en la atención médica. De muchas maneras, esto equivale a un ciclo. Puede comenzar con algo tan simple como una idea que se desarrolla en un laboratorio, se traslada a la atención directa del paciente y, si todo sale bien y resulta útil o beneficioso, pasa a ser el método estándar. Creo que una de las características tan singulares de la forma de investigar en Mayo es la concentración en el paciente, y es lo que realmente le ayuda a captar la atención de todos. SeccionesSolicite una ConsultaPanorama generalMédicosMédicos por sede y especialidadGrupos por especialidadConocimientos y categoríasInvestigaciónCostos y seguroRemisiones ORG-20308333 Centros y departamentos médicos Gastroenterología y Hepatología